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Tannins as Antiviral Agents
Neli Vilhelmova-Ilieva, Angel S. Galabov and Milka Mileva
Abstract
Tannins possess a variety of biological effects, not a small part of which is 
of medical significance. Tannins, isolated from plants as well as synthetically 
obtained, manifest activity against a large spectrum of viruses: enteroviruses 
(polio- and coxsackie-), caliciviruses (feline calicivirus, mouse norovirus), rota-
virus, influenza virus A, rhabdo- (vesicular stomatitis virus), paramyxoviruses 
(Sendai and Newcastle disease viruses), human immunodeficiency virus, herpes 
simplex virus, and adenoviruses. A special importance merits several ellagitannins 
manifesting pronounced effects against herpes simplex virus type 1 and 2 and on 
some herpes viruses affecting domestic animals, causing diseases of economic 
importance. An advantage of ellagitannins as anti-herpesvirus agents is that they 
have a non-nucleoside structure. Their targets are virus-specific proteins, so they 
retain activity against acyclovir-resistant strains of HSV types 1 and 2. Besides, 
these tannins manifest a synergistic effect with acyclovir when combined. Some 
initial results on their mechanism of action were carried out. In addition, it was 
found that most of the tannins have antioxidant properties in experimental models 
in vitro as well as in experimental influenza viral infection in mice.
Keywords: tannins, antiviral effect, antioxidant, herpes simplex virus,  
influenza virus
1. Introduction: tannins in medicine
For thousands of years throughout the world, tannins have been used in tra-
ditional medicines for the treatment of various health problems. They are used in 
the form of tea, coffee, and various extracts and in the daily intake of tannin-rich 
foods. They are also purposefully included as a component of many diets. Tannins 
are found in all parts of the plant—roots, stems, leaves, fruits, and seeds—which 
contribute to the existence of numerous natural sources of these substances.
Due to tannins’ astringent effects, herbs containing tannins are used to treat 
injured and inflamed tissues, including burns, and to stop bleeding and prevent 
infection. Herbs contain tannins. They are also used in the treatment of mouth 
and throat inflammation, gastritis, enteritis, irritating bowel disorders, and other 
conditions [1–3], due to their ability to bind very tightly to proteins by forming 
multiple hydrogen bonds between their phenolic groups and the -NH groups of the 
peptides. Precipitation or the shrinking of proteins—the so-called tanning effect—
then occurs, forming a protective layer on the surface of tissues.
Tannins have the ability to bind to metal ions in the body to form stable 
compounds called tannates. This property may have both positive and negative 
significance for human health. On the one hand, tannins can be used as an antidote 
for heavy metal poisoning. On the other hand, taking tannins daily, for example, 
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in tea or coffee, can cause calcium and iron deficiencies in the body and may cause 
osteoporosis and anemia [4].
Tannins are also effective inhibitors of certain enzymes. For example, wood-
fruticosin (woodfordin C) shows anti-topoisomerase II activity; and eugeniflorin 
D1 and D2, isolated from Eugenia uniflora L., and oenothein B effectively inhibit 
Epstein-Barr virus (EBV) DNA polymerase. Oenothein A and B, isolated from 
Epilobium species, appear to be potential inhibitors of the enzymes 5α-reductase 
and aromatase, which play important roles in the development of benign pros-
tatic hyperplasia. Researchers have suggested that the enzyme poly(ADP-ribose) 
glycohydrolase, an important factor in gene expression, DNA replication, and cell 
differentiation, can be inhibited by the oligomeric ellagitannins oenothein B and 
nobotanins B, E, and K. In addition, enzyme α-glucosidase (maltase), which may 
be important in the development of type-2 diabetes, is inhibited by chebulagic acid 
(isolated from Terminalia chebula), tellimagrandin I, and eugeniin (casuarictin) [5].
Research results indicate that the crude extract of Terminalia bellerica fruit (Tb.
Cr), which is rich in tannin content, induced a dose-dependent fall in the arterial 
blood pressure of rats. Tb.Cr inhibited the force and rate of atrial contractions, 
and this effect was due to a calcium antagonistic mechanism [6]. Tannins also 
exhibit antihypertensive activity in the body by inhibiting the effect of angiotensin 
I-converting enzyme (ACE) [7]. Hydrolysable tannins with pronounced antihyper-
tensive activity are castalagin and chebulinic acid as well as corilagin isolated from 
the leaves of Lumnitzera racemosa [8].
Important for human health is the antitumor activity different tannins show 
toward various tumors such as cervical and prostate cancer and malignant cells in 
the skin, breast, stomach, lung, esophagus, liver, and so on [9, 10], with several 
possible mechanisms of action. Ellagitannins possess the ability to bind to proteins 
located on the surface of the cell membrane, thus preventing the proliferation of 
metastatic cells. They can induce also apoptosis in tumor cells by inhibiting factors 
responsible for the formation of metastases. Another mechanism suggests that dur-
ing DNA replication, ellagitannins bind carcinogens into a complex, so they cannot 
cause mutation [11]. There is also evidence that ellagitannins reduce the negative 
effects of chemotherapy and radiation in cancer treatment [12].
Tannins also show antimicrobial activity, in both plants and animals. In plants, 
the effect is due to the inhibition of microbial enzymes that degrade the plant cell 
wall [13]. Inhibition also occurs with other microbial enzymes such as pectinase, 
xylanase, peroxidase, laccase, and glycosyl transferase. Two possible mechanisms 
of this antimicrobial activity are tannins binding to the proteins of microbial mem-
branes, damaging their structure and function, and tannins binding with essential 
metal ions [14]. Due to their antimicrobial activity, tannins can be used in the 
production and storage of certain foods to increase the shelf life of products [15].
The immunomodulatory activity of tannins has also been demonstrated, with 
different substances showing different mechanisms of action that enhance the 
functionality of macrophages [16–18] or stimulate the secretion of cytokines IL-1, 
IL-β2, and αTNF [18, 19].
2. Tannins as antiviral antioxidants
The overproduction of free radicals and the subsequent development of 
oxidative stress are implicated as pathogenic factors in a number of viral infections. 
Oxidative stress is a complex multifaceted biochemical condition, which occurs 
when there is an increase in oxidative damage to biomolecules and oxidation 
of nonprotein and protein thiols that regulate a cell’s oxidative balance [20]. 
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The cellular injury due to viral diseases caused by over generation of free radicals 
has been linked to over 200 clinical disorders [21].
It has been clearly established that many of viral infections trigger the produc-
tion of reactive oxygen (ROS) and nitrogen (RNS) species. This is particularly true 
for infections caused by the blood-borne hepatitis viruses (B, C and D), human 
immunodeficiency virus (HIV), influenza virus, herpes simplex virus, Epstein-Barr 
virus, respiratory syncytial virus, coxsackievirus B3 (CVB3), and others. For acute 
respiratory viral infections, ROS/RNS have been implicated in lung tissue injury 
and epithelial barrier dysfunction, which in turn increased susceptibility to second-
ary infections [22].
A variety of DNA viruses are associated with the increased oxidative stress that 
promotes DNA damage, high mutagenicity, and initiation and/or progression of 
neoplasia [23].
Phenolic compounds such as phenolic acids, flavonoids, tannins, and proantho-
cyanidins are widely distributed in plants and are a protective mechanism against 
OS. Several studies, including in vivo (in experimental animals) and epidemiological 
investigations, have demonstrated that phenolic compounds in foods possess positive 
attributes such as antioxidant potential, which is the basis of antiviral, antimicrobial, 
and antimutagenic activities. Compounds present in food that have potential anti-
oxidant activity include vitamins C, E, and K, phenols (phenolic acids, flavonoids, 
thymol, carvacrol, and tannins), and carotenoids [24, 25]. Thus, antioxidants, mainly 
those originating from natural products, are of great importance for human health.
Antioxidant therapy is becoming an attractive and effective alternative approach 
for the treatment of viral diseases. The antioxidant properties of apple polyphenol 
extract, which is rich in tannins, are effective against the development of influenza 
virus infection in mice—they improve survival rates and also significantly decrease 
lipid peroxidation and increase oxygen radical absorbance capacity (ORAC) in 
splenocytes [26].
Avian influenza is usually accompanied by virus invasion followed by the occur-
rence of oxidative stress and serious inflammation. The anti-inflammatory and 
antioxidant properties of tannin-rich extracts of Chaenomeles speciosa showed that 
the multiple effects of the isolates might play a cocktail-like role in the treatment of 
avian influenza, and C. speciosa components might be a potent source for antiviral 
and anti-inflammatory agents [27].
Pomegranate juice consumption reduces oxidative stress during influenza 
 infection [28].
Green tea is an important source of polyphenol antioxidants, which are also rich in 
tannins. Tea polyphenols possess antiviral properties believed to help protect against 
influenza virus. Oxidative stress and inflammation in the oral cavity, due to cigarette 
smoking and cigarettes’ deleterious compounds nicotine and acrolein, can be reduced 
by green tea polyphenols. Generally, green tea defends healthy cells from malignant 
transformation, and locally, it has the ability to induce apoptosis in oral cancer cells [29].
Finally, oxidative stress and the stress-mediated complications of viral infec-
tions successfully respond to antioxidant prevention. However, it should be kept 
in mind that antioxidants are not antivirals. Their function is more auxiliary, and 
they are particularly beneficial when used in combination therapy with specific 
viral inhibitors.
3. Tannins as antivirals
For a small fraction of today’s known viral diseases, there are vaccines that can 
be successfully applied. Medicaments that are used are also limited in number, and 
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in most cases, their use is accompanied by the appearance of side effects or the 
formation of resistant viral mutants, making therapy ineffective. Therefore, turning 
to nature to find effective therapies is a good solution to this problem. As mentioned 
earlier, tannins are a component of many plants. They are found in relatively high 
concentrations and exhibit significant biological activities. Tannin attack targets 
can carry out different stages of viral replication, including the extracellular virions 
themselves, their attachment to the cell, their penetration into the cell and the 
replication process in the host cell, as well as the assembling of new viral particles, 
transport proteins, polysaccharides, and viral enzymes [30, 31]. In almost all of the 
abovementioned stages, the tannin activity is due to their ability to bind perma-
nently to the proteins of the capsid or supercapside, either to specific viral enzymes 
required for viral replication or to newly synthesized viral proteins involved in the 
composition of the new viral particles.
Numerous plant extracts have been studied, in which tannins are the main 
component, and they have shown good results against the replication of different 
viruses. The resulting effects have been on both coated viruses (influenza viruses A/
H3N2 and A/H5N3, herpes simplex virus type 1 (HSV-1), vesicular stomatitis virus, 
Sendai virus and Newcastle disease viruses) [32, 33] and non-enveloped viruses 
(poliovirus, coxsackievirus, adenovirus, rotavirus, feline calicivirus, and mouse 
norovirus) [34].
The antiretroviral activity of Euphorbia hirta extracts with high tannin content has 
indicated a dose-dependent inhibition of reverse transcriptase activity in vitro [35].
Extracts of Hamamelis virginiana L. bark, with differing concentrations of 
tannins and individual tannins of defined structures, including pseudotannins, 
have been tested for effect against influenza A virus (IAV) and human papilloma-
virus (HPV) type 16 infections. The study demonstrated that the IAV life cycle is 
inhibited in the early and, to a minor extent, later steps and that HPV attachment 
is tannin-dependently inhibited. Of the investigated substances high molecular 
weight tannin inhibited both IAV receptor binding and neuraminidase activity. 
However, those with low molecular weight tannin inhibited neuraminidase but not 
hemagglutination [36].
Many tannins showing antiviral activity have been isolated and characterized. 
The hydrolyzable tannins chebulagic acid and punicalagin were identified as potent 
inhibitors of HCV entry [37]. The replication of human, porcine, and duck influ-
enza A virus in vitro was prevented by the hydrolyzable tannin strictinin [38].
Finally, many studies have been conducted on tannins’ effects against the 
replication of human immunodeficiency virus (HIV), and the results of the vari-
ous teams indicate that tannins have several targets of action in the HIV replicative 
cycle. Ellagitannins isolated from Tuberaria lignosa inhibited HIV’s entry into 
MT-2 cells [39]. There is evidence that ellagitannins suppressed HIV replication by 
inhibiting reverse transcriptase [40–44]. Other authors have reported on ellagitan-
nins (geraniin and corilagin) that reduced HIV replication by inhibiting the HIV-1 
protease and HIV-1 integrase enzymes [43].
4. Ellagitannins as antiherpesvirus agents
Various tannins have been tested for antiherpesviral activity. Ellagitannin 
geraniin possesses a virucidal effect against herpesviruses [45], and it inhibits the 
adsorption of HSV and HTLV-IIIB [46–49]. The hydrolyzable tannin casuarinin 
isolated from Terminalia arjuna Linn prevents the attachment of HSV-2 and its pen-
etration into the cell, and it also disturbs the late stages of infection [1]. Chebulagic 
acid and punicalagin—two hydrolysable tannins isolated from Terminalia chebula 
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Retz.—inactivate HSV-1 entry and the cell-to-cell spread of the virus by targeting 
HSV-1 glycoproteins [50]. Putranjivain A isolated from Euphorbia jolkini inhibits 
the entry of the virus and the late stages of HSV-2 replication in vitro [51].
Seven ellagitannins isolated from Phyllanthus myrtifolius and Phyllanthus urinary, 
and eugeniflorin D (1) and D (2) isolated from Eugenia uniflora L., are active against 
the DNA polymerase of EBV [52, 53]. Eucalyptus grandis extract containing euglobal-
G1 and euglobal-G3 shows antiviral activity against EBV, as do quassinoids (ailantinol 
B, ailantinol C, and ailanthone). Eugenol and eugenin isolated from Geum japonicum 
or Syzygium aromaticum show inactivating activity on viral DNA polymerase and 
thus inhibit acyclovir-resistant TK-deficient HSV-1 virus, wild HSV-2, and EBV [52, 
54–56]. The EBV DNA polymerase is also inhibited by ellagitannins contained in 
Phyllanthus myrtifolius extracts and Phyllanthus urinaria (Euphorbiaceae), probably 
due to the corilagin moiety of these tannins. The tannin samarangenin B contained 
in the alcoholic extract of Limonium sinensis significantly suppresses HSV-1 multi-
plication [57]. And cowaniin isolated from Cowania mexicana (Rosaceae) exhibits an 
inhibitory effect on the activation of EBV early antigens [58].
Our studies on the antiviral activity of tannins have been mainly related to 
substances that belong to the group of nonahydroxyterphenoil-bearing C-glucosidic 
ellagitannins. We investigated the activity of three compounds—castalagin, 
vescalagin, and grandin isolated from powdered pedunculate oak (i.e., Quercus 
robur)—against the replication of two strains of HSV-1 (DA and Victoria) suscep-
tible to acyclovir (ACV), one HSV-1 strain resistant to ACV (R-100), two HSV-2 
strains susceptible to ACV (XA and Bja), and one HSV-2 strain resistant to ACV 
(PU) (Table 1) [59, 60].
Currently existing therapy against HSV infections is based on the administration 
of nucleoside analogues, among which ACV has had the broadest application. A 
disadvantage of this therapy is the rapid formation of resistant mutants [61].
All three investigated ellagitannins showed remarkable antiviral activity against 
all strains of HSV-1, the strongest being castalagin’s action against the DA strain 
(SI = 5390.0) followed by vescalagin’s action against that strain (SI = 4546.0), and 
these effects were greater than that of ACV. The effects on the replication of HSV-2 
strains, although less pronounced than those on HSV-1, were significant. The stron-
gest effects were seen on strain XA, with the following SI values: vescalagin = 378.9, 
castalagin = 336.9, and grandinin = 208.8.
The activity of the three ellagitannins was also determined in relation to the 
replication of three of the most common and important HSV-1 strains of economic 
importance, namely, pseudorabies virus or Suid herpesvirus 1 (SuHV-1), bovine 
Compounds SI = CC50/IC50
HSV-1 HSV-2




Strains sensitive to 
ACV
Strain resistant to 
ACV
DA Victoria R-100 XA Bja PU
Castalagin 5390.0 4498.0 1047.5 336.9 89.9 97.4
Vescalagin 4546.0 909.0 900.0 378.9 123.9 117.4
Grandinin 1183.0 88.7 650.0 208.8 71.0 103.1
ACV 1270.5 972.8 25.3 790.2 810.5 29.0
*The data for strains DA and DX are the original ones; the rest are from references [59, 60].
Table 1. 
Effect of ellagitannins on HSV replication.*
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herpesvirus-1 (BoHV-1), and caprine herpesvirus-1 (CapHV-1). The effect of the 
three ellagitannins was strongest against SuHV-1, with the activity of castalagin 
(SI = 336.8) and vescalagin (SI = 309) being on the order of ACV, while grandinin 
exhibited a moderate effect (SI = 40.8). The activity of the three ellagitannins 
against BoHV-1 was comparatively weaker but still significant (castalagin SI = 45, 
vescalagin SI = 42.5, grandinin SI = 32.3). Activity against the CapHV-1 strain had 
limited values.
Antiviral activity against HSV-1 (Victoria strain) was also determined for nine 
ellagitannins, of which six are natural compounds (castalin, vescalin, acutissimin 
A, epiacutissimins (EPI) A and B, mongolicain) and three are vescalagin synthetic 
derivatives (VgSBuSH, VgSOctSH, VgOMe). Thirteen gallotannin-type compounds 
[Gal-01A, Gal-01B, Gal-02A, Gal-02B, Gal-03 M, Gal-04A, Gal-04B, Gal-05 M, 
Gal-07, Gal-08, Gal-09, Gal-11 M (tannic acid), Gal-12 (gallic acid)] as well as 
Gal-13 and Gal-14 (ellagic acid)] were also tested. Generally, the group of ellagitan-
nins exhibited greater activity, with only castalin and vescalin, from the natural 
products, and one of the synthetic derivatives (VgSOctSH) showing no activity. 
The remaining four natural components exhibited more pronounced activity than 
did the synthetic products, with the strongest effect showing for Epi B and Epi A 
(Table 2). Only three of the gallotannins—Gal-04A, Gal-04B, and Gal-11 M—
showed activity against HSV-1 replication (Table 2) [62].
In order to control HSV infections, especially in immunosuppressed patients, it 
is necessary to treat them with antiherpetic preparations. However, their systemic 
use leads to the selection and/or formation of resistant strains. Given the hetero-
geneity of the viral population, naturally resistant variants are present. Therefore, 
the use of new approaches to the treatment of HSV infections [63, 64], namely, by 
combination therapy with two or more chemotherapeutics with synergistic action, 
is being sought. In these new approaches, synergistic combinations of two and more 
preparations are used to attack multiple viral targets simultaneously. This reduces 
the possibility of the formation and/or selection of resistant mutants. Even more, 
the therapeutic doses are abruptly reduced, eliminating any side effects. Data have 
been reported for combinations of antiviral agents showing a synergistic or additive 
effect on HSV [65–68].
Each of the three ellagitannins—castalagin, vescalagin, and grandinin—was 
administered in combination with ACV, and their effects against the replication 
Compound MM (g/mol) CC50 (μM) IC50 (μM) SI =CC50/IC50
Epi A 1207 >1000*** 18.0 ± 0.77*** >55.5
Epi B 1207 >1000*** 16.5 ± 0.14*** >60.6
Acutissimin 1207 >640*** 18.4 ± 1.2*** >34.78
Mongolicain 1177 >640*** 19.7 ± 0.84*** >32.5
VgSBuSH 1039 >640*** 26.0 ± 1.76*** >24.6
VgOMe 949 >640*** 29.0 ± 2.89*** >22.0
Gal-04A 1701 >200*** 7.0 ± 1.2** >28.5
Gal-04B 1701 >100*** 2.8 ± 0.53* >35.7
Gal-11 M(TA) 1701 >100*** 4.0 ± 0.07* >25.0
The table presents data partially contained in Ref. [62].*p > 0.05.
**p < 0.05.
***p < 0.001, when comparing the value of each gallotannin against ACV (CC50 = 1296.0 μM; IC50 = 1.47 μM) [59].
Table 2. 
Effect of tannins on the replication of HSV-1 in MDBK cell.
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of HSV-1 and HSV-2 strains sensitive and resistant to ACV’s effect were markedly 
synergistic [59, 60]. To evaluate the effect of the combinations, we employed the 
three-dimensional model system developed by Prichard and Shipman [69] using 
the computer program MacSynergy ™ II [70]. The program calculates the volume 
of synergy in μM2%, where values between 50 and 100 μM2% indicate moderate 
synergy (this interaction may be important in vivo) and values over 100 μM2% 
indicate strong synergy (these are more likely to be important in vivo). The 
strongest synergistic effect was seen in the combinations administered against 
the ACV-resistant HSV-1 strain, and the effect was also pronounced in the ACV-
sensitive HSV-1 strain. The combined effect on the HSV-2 strains was weaker but 
also significant: in both the resistant and sensitive strains, the effect was on the 
same order of magnitude (Table 3).
The telling synergistic effect of all three ellagitannins shows that they have a dif-
ferent mechanism of action against HSV reproduction compared to that of ACV. The 
exact mechanism of antiviral activity of tannins has not been studied in detail.
To elucidate the mechanism of anti-herpes activity of tannins, we used a sub-
stance that showed activity similar to that of acyclovir, namely, castalagin.
When monitoring castalagin’s effect on extracellular virions, we found that it 
was markedly time dependent. At the first time interval—15 min—the effect was 
negligible, but at 30 min, the effect was already significant, and as time increased, the 
virucidal effect intensified. This effect was also influenced by the temperature at which 
it occurred, with the effect at 37°C being stronger than that at room temperature [71].
Castalagin’s effect on the attachment of HSV-1 virions to MDBK cells was time 
dependent, and it was also dependent on the concentration of castalagin and the 
number of infectious viral particles. The inhibitory effect was reported at 30 min 
(Δlog 1.7), and it increased with the time of impact, reaching a value of Δlog 3.2 at 
60 min. The most remarkable effect was observed when using castalagin at a maxi-
mum non-toxic concentration of 10 μM and then reducing its effect with a decrease 
in its concentration [71].
Using a one-staged viral replicative cycle in a timing-of-addition study, we tested 
castalagin’s effect on the production of infectious virions during the replication 
cycle of ACV-sensitive HSV-1, Victoria strain. The effect of adding castalagin at 
0 hours was most pronounced, and the effect remained significant when adding the 
ellagitannin at up to 4 hours. After this period of time, the addition of the substance 
had no particular effect, and after 15 hours, a statistically significant effect was 
not observed. From these results, it can be concluded that castalagin affects earlier 
stages of the viral replicative cycle [71].
These results demonstrate a very high activity of the ellagitannin derivative 
castalagin toward human herpes simplex viruses 1 and 2. Its effect is on the order of 
the most efficient anti-HSV compound, acyclovir, which is widely used in clinical 
practice. In addition, castalagin manifested a marked activity against ACV-resistant 
Compound HSV-1 HSV-2
Victoria R-100 Bja PU
Castalagin 222.06 222.13 71.62 97.78
Vescalagin 205.09 324.44 87.56 79.11
Grandinin 106.0 314.53 132.78 106.12
*The table is originally constructed with results presented in Refs. [59, 60].
Table 3. 
Synergistic effect between ellagitannins and acyclovir (μM2%).*
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HSV strains, and its combination effects with ACV could be characterized as syner-
gistic. Another advantage of this substance is its non-nucleoside chemical structure.
Castalagin could be considered as a candidate for in vivo testing on experimental 
HSV infections in laboratory animals, such as HSV-1-induced skin infection in 
mice, encephalitis in newborn mice, eye infection in rabbits, as well as HSV-2 geni-
tal infection in mice. A very important step in the characterization of the anti-HSV 
effect of castalagin is the determination of its target in the herpesvirus replication 
cycle via molecular genetic analysis.
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